SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil
DOI:
https://doi.org/10.1590/S1678-9946202163036Palavras-chave:
SARS-CoV-2, COVID-19, Reinfection, Variants of concern, P.1 lineageResumo
Reinfection by the severe acute respiratory syndrome coronavirus type 2 (SARS-COV-2) has been reported in many countries, suggesting that the virus may continue to circulate among humans despite the possibility of local herd immunity due to massive previous infections. The emergence of variants of concern (VOC) that are more transmissible than the previous circulating ones has raised particular concerns on the vaccines effectiveness and reinfection rates. The P.1 lineage was first identified in December 2020 in Manaus city and is now globally spread. We report the first case of reinfection of SARS-CoV-2 caused by the P.1 variant outside of Manaus. The potential of these new variants to escape naturally and vaccine- induced immunity highlights the need for a global vigilance.
Downloads
Referências
Downloads
Publicado
Edição
Seção
Licença
Direitos autorais (c) 2021 Camila Malta Romano, Alvina Clara Felix, Anderson Vicente de Paula, Jaqueline Góes de Jesus, Pamela S. Andrade, Darlan Cândido, Franciane M. de Oliveira, Andreia C. Ribeiro, Francini C. da Silva, Marta Inemami, Angela Aparecida Costa, Cibele O. D. Leal, Walter Manso Figueiredo, Claudio Sergio Pannuti, William M. de Souza, Nuno Rodrigues Faria, Ester Cerdeira Sabino

Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial 4.0 International License.
Dados de financiamento
-
Fundação de Amparo à Pesquisa do Estado de São Paulo
Números do Financiamento 2019/03859-9 -
Fundação de Amparo à Pesquisa do Estado de São Paulo
Números do Financiamento 2018/14389-0; -
Medical Research Council
Números do Financiamento (MR/S0195/1) -
John Fell Fund, University of Oxford
Números do Financiamento 005166 -
Fundação de Amparo à Pesquisa do Estado de São Paulo
Números do Financiamento 2017/13981-0, 2019/24251-9 -
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Números do Financiamento 408338/2018-0 -
Wellcome Trust
Números do Financiamento 204311/Z/16/Z